Journal ArticleThe Lancet. Rheumatology · July 2025
BackgroundIn patients with systemic sclerosis, it is common practice to treat interstitial lung disease (ILD) in patients in whom progression has already occurred. We sought to clarify whether observed progression of systemic sclerosis-associated ...
Full textCite
Journal ArticleRMD open · February 2025
BackgroundWhile the presence of distinct imaging abnormalities by high-resolution CT (HRCT) defines interstitial lung disease (ILD), there is a relative lack of validated methods to quantify these abnormalities in clinical practice, limiting ILD s ...
Full textCite
Journal ArticleActa oncologica (Stockholm, Sweden) · May 2024
BackgroundWhether sex is an independent prognostic factor in lung cancer survival is the subject of ongoing debate. Both large national registries and single hospital studies have shown conflicting findings. In this study, we explore the impact of ...
Full textCite
Journal ArticleBMC cardiovascular disorders · April 2024
BackgroundCOVID-19 has been associated with cardiac troponin T (cTnT) elevations and changes in cardiac structure and function, but the link between cardiac dysfunction and high-sensitive cardiac troponin T (hs-cTnT) in the acute and convalescent ...
Full textCite
Journal ArticleErs Monograph · January 1, 2024
Pulmonary fibrosis (PF) comprises a group of chronic fibrotic ILDs that carry a substantial risk of progressive respiratory failure and death. As such, PF represents an important indication for LTx. Specific ILD subtypes may be idiopathic, related to rheum ...
Full textCite
Journal ArticleBMC pulmonary medicine · April 2023
BackgroundFor interpretation of pulmonary function tests (PFTs), reference values based on sex, age, height and ethnicity are needed. In Norway, the European Coal and Steel Community (ECSC) reference values remain widely used, in spite of recommen ...
Full textCite
Journal ArticleERJ open research · March 2023
COVID-19 primarily affects the respiratory system. We aimed to evaluate how pulmonary outcomes develop after COVID-19 by assessing participants from the first pandemic wave prospectively 3 and 12 months following hospital discharge. Pulmonary outcomes incl ...
Full textCite
Journal ArticleFrontiers in medicine · January 2023
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease characterized by damage to the alveolar epithelium, leading to fibrosis and excessive accumulation of extracellular matrix in the interstitium of the lung. In the presen ...
Full textCite
Journal ArticleFrontiers in psychiatry · January 2022
ObjectiveTo assess the trajectory of symptoms and symptom-defined post-traumatic stress disorder (PTSD) from 1.5 to 12 months after hospitalization for COVID-19 and determine risk factors for persistent symptoms and PTSD.MethodsThis was a ...
Full textCite
Journal ArticleRespirology (Carlton, Vic.) · October 2021
Background and objectiveAntifibrotic therapy with nintedanib or pirfenidone slows disease progression and reduces mortality in patients with idiopathic pulmonary fibrosis (IPF). However, patients with advanced IPF, as defined by forced vital capac ...
Full textCite
Journal ArticleClinical transplantation · August 2021
BackgroundLoss of bone mineral and skeletal muscle mass is common after lung transplantation (LTx), and physical activity (PA) may prevent further deterioration. We aimed to assess the effects of 20-week high-intensity training (HIT) on body compo ...
Full textCite
Journal ArticleJAMA · May 11, 2021
IMPORTANCE: Alteration in lung microbes is associated with disease progression in idiopathic pulmonary fibrosis. OBJECTIVE: To assess the effect of antimicrobial therapy on clinical outcomes. DESIGN, SETTING, AND PARTICIPANTS: Pragmatic, randomized, unblin ...
Full textLink to itemCite
Journal ArticleThe European respiratory journal · April 2021
The long-term pulmonary outcomes of coronavirus disease 2019 (COVID-19) are unknown. We aimed to describe self-reported dyspnoea, quality of life, pulmonary function and chest computed tomography (CT) findings 3 months following hospital admission for COVI ...
Full textCite
Journal ArticleClinical transplantation · March 2021
Chronic lung allograft dysfunction (CLAD) is a serious complication after lung transplantation (LuTx) and is associated with elevated proportions of neutrophils in bronchoalveolar lavage (BAL). Induced sputum is a less-invasive sampling method than BAL and ...
Full textCite
Journal ArticleClinical transplantation · January 2021
BackgroundWhile expected need for intensive care after lung transplantation (LTx) does not normally affect organ allocation, it would be useful to estimate whether intensive care capacity is limited. The aim of this study was to assess factors ava ...
Full textCite
Journal ArticleMedicine (Baltimore) · November 20, 2020
Hospitalizations are common in patients with idiopathic pulmonary fibrosis (IPF) and are associated with high mortality. We used data from the Premier Healthcare Database to determine in-hospital mortality rates and the factors associated with in-hospital ...
Full textLink to itemCite
Journal ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · September 2020
BackgroundPeak oxygen uptake (VO2peak) remains low after lung transplantation (LTx). We evaluated the effect of high-intensity interval training (HIIT) on VO2peak, muscular strength, health-related quality of life (HRQOL), pu ...
Full textCite
Journal ArticleBMJ open respiratory research · June 2020
IntroductionIdiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated interstitial lung disease (SSc-ILD) are fibrotic ILDs with divergent disease populations. Little is known about health-related quality of life (HRQL) in SSc-ILD rela ...
Full textCite
Journal ArticleRespir Res · March 12, 2020
Compelling data have linked disease progression in patients with idiopathic pulmonary fibrosis (IPF) with lung dysbiosis and the resulting dysregulated local and systemic immune response. Moreover, prior therapeutic trials have suggested improved outcomes ...
Full textLink to itemCite
Journal ArticleRespiration; international review of thoracic diseases · January 2020
BackgroundLow cardiorespiratory fitness and inactivity are common after lung transplantation (LTx). The causes of exercise intolerance are incompletely understood.ObjectivesThe aim of this study was to objectively assess cardiorespiratory ...
Full textCite
Journal ArticleFrontiers in immunology · January 2020
Common variable immunodeficiency (CVID) is characterized not only by recurrent bacterial infections, but also autoimmune and inflammatory complications including interstitial lung disease (ILD), referred to as granulomatous-lymphocytic interstitial lung di ...
Full textCite
Journal ArticleLung · December 2019
PURPOSE: In patients with idiopathic pulmonary fibrosis (IPF), hospitalizations are associated with high mortality. We sought to determine in-hospital mortality rates and factors associated with in-hospital mortality in patients with IPF. METHODS: Patients ...
Full textLink to itemCite
Journal ArticleChest · September 2019
BACKGROUND: Pulmonary fibrosis (PF) is the most common disease indication for lung transplantation. Our recent work implicated an excess of rare genetic variants in the telomere-related genes TERT, RTEL1, and PARN in PF disease risk. The impact of such var ...
Full textLink to itemCite
Journal ArticleTransplantation · April 2019
BackgroundOrgans from older donors are increasingly used in lung transplantation, and studies have demonstrated that this could be safe in selected recipients. However, which recipient groups that have the largest benefit of older organs are uncle ...
Full textCite
Journal ArticleHeart · November 2018
OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is associated with the development of atrial fibrillation (AF), and may complicate treatment of AF. We examined the association between COPD and symptoms, quality of life (QoL), treatment and outcomes ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · August 2017
BACKGROUND: Surgical lung biopsy contributes to establishing a specific diagnosis among many patients with interstitial lung disease (ILD). The risks of death and respiratory failure associated with elective thoracoscopic surgical lung biopsy, and patient ...
Full textLink to itemCite
Journal ArticleAm J Respir Crit Care Med · July 1, 2017
RATIONALE: Idiopathic pulmonary fibrosis (IPF) is an increasingly recognized, often fatal lung disease of unknown etiology. OBJECTIVES: The aim of this study was to use whole-exome sequencing to improve understanding of the genetic architecture of pulmonar ...
Full textLink to itemCite
Journal ArticleAnn Am Thorac Soc · February 2017
RATIONALE: Lung transplantation is an accepted and increasingly employed treatment for advanced lung diseases, but the anticipated survival benefit of lung transplantation is poorly understood. OBJECTIVES: To determine whether and for which patients lung t ...
Full textLink to itemCite
Journal ArticleClin Transplant · February 2017
BACKGROUND: Impaired psychological function is common among lung transplant candidates and may affect clinical outcomes following transplantation. Although numerous studies have examined the relationship between pretransplant depression, quality of life (Q ...
Full textLink to itemCite
Journal ArticleRespir Med · December 2016
BACKGROUND: The complex interaction between pulmonary function, cardiac function and adverse cardiovascular events has only been partially described. We sought to describe the association between pulmonary function with left heart structure and function, a ...
Full textLink to itemCite
Journal ArticleInt J Cardiol · January 1, 2016
BACKGROUND: Comorbid chronic obstructive pulmonary disease (COPD) is associated with poor outcomes among patients with cardiovascular disease. The risks of stroke and mortality associated with COPD among patients with atrial fibrillation are not well under ...
Full textLink to itemCite
Journal ArticlePsychosom Med · 2016
OBJECTIVE: To examine the prognostic value of select biobehavioral factors in patients with chronic obstructive pulmonary disease (COPD) in a secondary analysis of participants from the INSPIRE-II trial. METHODS: Three hundred twenty-six outpatients with C ...
Full textLink to itemCite
Journal ArticleBMJ Open Respir Res · 2016
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterised by progressive loss of lung function. Its clinical course is variable but ultimately fatal. There is a need for a multicentre patient registry incorporatin ...
Full textLink to itemCite
Journal ArticleAnn Am Thorac Soc · December 2015
RATIONALE: Older patients are at high risk of death and rehospitalization after hospitalizations for acute exacerbations of chronic obstructive pulmonary disease (AE-COPD). Emergency department visits comprise a substantial portion of acute care encounters ...
Full textLink to itemCite
Journal ArticleLancet Respir Med · May 2015
BACKGROUND: Mortality is an impractical primary endpoint for clinical trials in patients with idiopathic pulmonary fibrosis who have mild-to-moderate physiological impairment because event rates are low. Change in forced vital capacity (FVC) is widely acce ...
Full textLink to itemCite
Journal ArticleAnn Am Thorac Soc · March 2015
RATIONALE: The 2011 combined Global Initiative for Chronic Obstructive Lung Disease (GOLD) assessment incorporates symptoms, exacerbation history, and spirometry in discriminating risk of exacerbations in patients with chronic obstructive pulmonary disease ...
Full textLink to itemCite
Journal ArticleJ Crit Care · February 2015
BACKGROUND: Delirium is relatively common after lung transplantation, although its prevalence and prognostic significance have not been systematically studied. The purpose of the present study was to examine pretransplant predictors of delirium and the sho ...
Full textLink to itemCite
Journal ArticleAnn Am Thorac Soc · December 2014
RATIONALE: Neurocognitive impairments are associated with reduced quality of life and may adversely affect medical compliance, but their prevalence after lung transplantation has not been extensively studied. OBJECTIVES: To examine the frequency of neuroco ...
Full textLink to itemCite
Journal ArticlePsychosom Med · October 2014
OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is associated with increased morbidity and mortality and reduced quality of life (QoL). Novel interventions are needed to improve outcomes in COPD patients. The present study assessed the effects of a ...
Full textLink to itemCite
Journal ArticleDiabetes Care · October 2009
OBJECTIVE: Insulin resistance and beta-cell dysfunction both are important contributors to the pathogenesis of type 2 diabetes. Exercise training improves insulin sensitivity, but its effects on beta-cell function are less well studied. RESEARCH DESIGN AND ...
Full textLink to itemCite
Journal ArticlePhysiol Genomics · February 2, 2009
Endurance exercise (EE) leads to beneficial alterations in skeletal muscle lipid metabolism in overweight and obese individuals; however, the mechanisms of these improvements are poorly understood. The primary goal of the current investigation was to test ...
Full textLink to itemCite
Journal ArticleAm J Physiol Endocrinol Metab · August 2008
Small LDL and HDL particle size are characteristic of a proatherogenic lipoprotein profile. Aerobic exercise increases these particle sizes. Although visceral adipose tissue (VAT) has been strongly linked with dyslipidemia, the importance of intermuscular ...
Full textLink to itemCite